Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer

Amanda F Baker, Mei Y. Koh, Ryan R. Williams, Brian James, Huamin Wang, Wendy R. Tate, Alfred Gallegos, Daniel D. Von Hoff, Haiyong Han, Garth Powis

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objective: To investigate the expression of thioredoxin-interacting protein (TXNIP) during hypoxia and its dependency on hypoxiainducible factor 1α (HIF-1α) in pancreatic cancer cell lines. Methods: MiaPaCa-2 pancreatic cancer cells were transiently transfected with siRNA to HIF-1α and TXNIP protein measured after growth in normoxia or hypoxia. In addition, HIF-1α dependency was assessed by transiently transfecting MiaPaCa-2 pancreatic cancer cells with a mutated oxygen degradation domain resulting in stable HIF-1α expression in normoxic conditions. Panc-1 pancreatic cancer cells with low endogenous TXNIP expression were stably transfected with TXNIP, and cell survival and response to platinum cancer agents were tested. Quantitative immunohistochemistry was utilized to measure the expression of TXNIP and thioredoxin 1 in human pancreatic cancer tissues. Results: Thioredoxin- interacting protein was induced during hypoxia in pancreatic cancer cells in a HIF-1α-dependent manner. Overexpression of TXNIP in the Panc-1 cells resulted in a higher basal apoptosis and increased sensitivity to cisplatin and oxaliplatin. A negative correlation was observed between TXNIP and thioredoxin 1 expression in human pancreatic cancer tissues. Conclusions: Thioredoxin-interacting protein, a putative tumor suppressor gene, is induced in response to hypoxia in a HIF- 1α-dependent manner in pancreatic cancer cells, resulting in increased apoptosis and increased sensitivity to platinum anticancer therapy. Increased TXNIP may be a mechanism to counterbalance the prosurvival effects of HIF-1α.

Original languageEnglish (US)
Pages (from-to)178-186
Number of pages9
JournalPancreas
Volume36
Issue number2
DOIs
StatePublished - Mar 2008

Fingerprint

Hypoxia-Inducible Factor 1
Thioredoxins
Pancreatic Neoplasms
Genes
Proteins
oxaliplatin
Platinum
Apoptosis
Tumor Suppressor Genes
Small Interfering RNA
Cisplatin
Cell Survival
Immunohistochemistry

Keywords

  • HIF-1α
  • Hypoxia
  • Pancreatic cancer
  • siRNA
  • Thioredoxin
  • TXNIP

ASJC Scopus subject areas

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Gastroenterology

Cite this

Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer. / Baker, Amanda F; Koh, Mei Y.; Williams, Ryan R.; James, Brian; Wang, Huamin; Tate, Wendy R.; Gallegos, Alfred; Von Hoff, Daniel D.; Han, Haiyong; Powis, Garth.

In: Pancreas, Vol. 36, No. 2, 03.2008, p. 178-186.

Research output: Contribution to journalArticle

Baker, AF, Koh, MY, Williams, RR, James, B, Wang, H, Tate, WR, Gallegos, A, Von Hoff, DD, Han, H & Powis, G 2008, 'Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer', Pancreas, vol. 36, no. 2, pp. 178-186. https://doi.org/10.1097/MPA.0b013e31815929fe
Baker, Amanda F ; Koh, Mei Y. ; Williams, Ryan R. ; James, Brian ; Wang, Huamin ; Tate, Wendy R. ; Gallegos, Alfred ; Von Hoff, Daniel D. ; Han, Haiyong ; Powis, Garth. / Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer. In: Pancreas. 2008 ; Vol. 36, No. 2. pp. 178-186.
@article{abf27bd635514245bf412edf9be98c0b,
title = "Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer",
abstract = "Objective: To investigate the expression of thioredoxin-interacting protein (TXNIP) during hypoxia and its dependency on hypoxiainducible factor 1α (HIF-1α) in pancreatic cancer cell lines. Methods: MiaPaCa-2 pancreatic cancer cells were transiently transfected with siRNA to HIF-1α and TXNIP protein measured after growth in normoxia or hypoxia. In addition, HIF-1α dependency was assessed by transiently transfecting MiaPaCa-2 pancreatic cancer cells with a mutated oxygen degradation domain resulting in stable HIF-1α expression in normoxic conditions. Panc-1 pancreatic cancer cells with low endogenous TXNIP expression were stably transfected with TXNIP, and cell survival and response to platinum cancer agents were tested. Quantitative immunohistochemistry was utilized to measure the expression of TXNIP and thioredoxin 1 in human pancreatic cancer tissues. Results: Thioredoxin- interacting protein was induced during hypoxia in pancreatic cancer cells in a HIF-1α-dependent manner. Overexpression of TXNIP in the Panc-1 cells resulted in a higher basal apoptosis and increased sensitivity to cisplatin and oxaliplatin. A negative correlation was observed between TXNIP and thioredoxin 1 expression in human pancreatic cancer tissues. Conclusions: Thioredoxin-interacting protein, a putative tumor suppressor gene, is induced in response to hypoxia in a HIF- 1α-dependent manner in pancreatic cancer cells, resulting in increased apoptosis and increased sensitivity to platinum anticancer therapy. Increased TXNIP may be a mechanism to counterbalance the prosurvival effects of HIF-1α.",
keywords = "HIF-1α, Hypoxia, Pancreatic cancer, siRNA, Thioredoxin, TXNIP",
author = "Baker, {Amanda F} and Koh, {Mei Y.} and Williams, {Ryan R.} and Brian James and Huamin Wang and Tate, {Wendy R.} and Alfred Gallegos and {Von Hoff}, {Daniel D.} and Haiyong Han and Garth Powis",
year = "2008",
month = "3",
doi = "10.1097/MPA.0b013e31815929fe",
language = "English (US)",
volume = "36",
pages = "178--186",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer

AU - Baker, Amanda F

AU - Koh, Mei Y.

AU - Williams, Ryan R.

AU - James, Brian

AU - Wang, Huamin

AU - Tate, Wendy R.

AU - Gallegos, Alfred

AU - Von Hoff, Daniel D.

AU - Han, Haiyong

AU - Powis, Garth

PY - 2008/3

Y1 - 2008/3

N2 - Objective: To investigate the expression of thioredoxin-interacting protein (TXNIP) during hypoxia and its dependency on hypoxiainducible factor 1α (HIF-1α) in pancreatic cancer cell lines. Methods: MiaPaCa-2 pancreatic cancer cells were transiently transfected with siRNA to HIF-1α and TXNIP protein measured after growth in normoxia or hypoxia. In addition, HIF-1α dependency was assessed by transiently transfecting MiaPaCa-2 pancreatic cancer cells with a mutated oxygen degradation domain resulting in stable HIF-1α expression in normoxic conditions. Panc-1 pancreatic cancer cells with low endogenous TXNIP expression were stably transfected with TXNIP, and cell survival and response to platinum cancer agents were tested. Quantitative immunohistochemistry was utilized to measure the expression of TXNIP and thioredoxin 1 in human pancreatic cancer tissues. Results: Thioredoxin- interacting protein was induced during hypoxia in pancreatic cancer cells in a HIF-1α-dependent manner. Overexpression of TXNIP in the Panc-1 cells resulted in a higher basal apoptosis and increased sensitivity to cisplatin and oxaliplatin. A negative correlation was observed between TXNIP and thioredoxin 1 expression in human pancreatic cancer tissues. Conclusions: Thioredoxin-interacting protein, a putative tumor suppressor gene, is induced in response to hypoxia in a HIF- 1α-dependent manner in pancreatic cancer cells, resulting in increased apoptosis and increased sensitivity to platinum anticancer therapy. Increased TXNIP may be a mechanism to counterbalance the prosurvival effects of HIF-1α.

AB - Objective: To investigate the expression of thioredoxin-interacting protein (TXNIP) during hypoxia and its dependency on hypoxiainducible factor 1α (HIF-1α) in pancreatic cancer cell lines. Methods: MiaPaCa-2 pancreatic cancer cells were transiently transfected with siRNA to HIF-1α and TXNIP protein measured after growth in normoxia or hypoxia. In addition, HIF-1α dependency was assessed by transiently transfecting MiaPaCa-2 pancreatic cancer cells with a mutated oxygen degradation domain resulting in stable HIF-1α expression in normoxic conditions. Panc-1 pancreatic cancer cells with low endogenous TXNIP expression were stably transfected with TXNIP, and cell survival and response to platinum cancer agents were tested. Quantitative immunohistochemistry was utilized to measure the expression of TXNIP and thioredoxin 1 in human pancreatic cancer tissues. Results: Thioredoxin- interacting protein was induced during hypoxia in pancreatic cancer cells in a HIF-1α-dependent manner. Overexpression of TXNIP in the Panc-1 cells resulted in a higher basal apoptosis and increased sensitivity to cisplatin and oxaliplatin. A negative correlation was observed between TXNIP and thioredoxin 1 expression in human pancreatic cancer tissues. Conclusions: Thioredoxin-interacting protein, a putative tumor suppressor gene, is induced in response to hypoxia in a HIF- 1α-dependent manner in pancreatic cancer cells, resulting in increased apoptosis and increased sensitivity to platinum anticancer therapy. Increased TXNIP may be a mechanism to counterbalance the prosurvival effects of HIF-1α.

KW - HIF-1α

KW - Hypoxia

KW - Pancreatic cancer

KW - siRNA

KW - Thioredoxin

KW - TXNIP

UR - http://www.scopus.com/inward/record.url?scp=45549106739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549106739&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e31815929fe

DO - 10.1097/MPA.0b013e31815929fe

M3 - Article

C2 - 18376310

AN - SCOPUS:45549106739

VL - 36

SP - 178

EP - 186

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 2

ER -